1US FDA.FDA approves new drug for schizophrenia[EB/OL].[2007-06-20].http://www.fda.gov/bbs/topics/NEWS/2006/NEW01534.html.
2KENNIS L E J,GUIDO G,VANDENBERK J K.Novel 1,2-benzisoxazol-3-yl and 1,2-benzisoxazol-3-yl derivatives:EP,196132[P].1986-10-01.
3JANSSEN C G M,KNAEPS A G,KENNIS L E J,et al.Pharmaceuticals containing antipsychotic 3-piperidinyl-1,2-benzisoxazoles:US,5158952[P].1992-10-27.
4JANSSEN C G M,KNAEPS A G,KENNIS L E J,et al.Preparation of 3-[(4-oxopyrido[1,2-a] pyrimidin-3-yl)piperidin-4-yl] 1,2-benzisoxazoles as antipsychotics:EP,368388[P].1990-05-16.
6KRAMER M,SIMPSON G,MACIULIS V,et al.Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia:a randomized,double-blind,placebo-controlled study[J].J Clin Psychopharmacol,2007,27(1):6-14.
7JANSSEN.FDA approves Invega for long-term maintenance treatment of schizophrenia[EB/OL].[2007-05-05].http://www.janssen.com/html/cjan/news _ release.jsp?item= 042707 _ 2.
7US FDA.FDA Approves New Drug for Schizophrenia[EB/OL].[2006-12-20].http://www.fda.gov/News-Events/ Newsroom/PressAnnouncernents/2006/ucm108812.htm.
8Kankan RN,Rao DR,Pathi SL.Process for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes:WO,2009047499[P].2009-04-16.(CA 2009,150:423221).
9Barti J,Benovsky E Krajcovic J.Synthesis of paliperidone:WO,2009074333[P].2009-06-18.(CA2009,151:56864).
10Dolitzky BZ,Shapiro E,Ini S,et al.Process for the synthesis of CMHTP and intermediates thereof:US,20080214809[P].2008-09-04.(CA 2008,149:307878).
